Anecortave Acetate in Patients With Exudative Age-related Macular Degeneration (AMD)

NCT00299507 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

240

Enrollment

INDUSTRY

Sponsor class

Conditions

Macular Degeneration

Interventions

DRUG: Anecortave Acetate Sterile Suspension, 30 mg/mL
DRUG: Anecortave Acetate Sterile Suspension, 60 mg/mL
OTHER: Anecortave Acetate Vehicle

Sponsor

Alcon Research